Item Type: |
Article |
Authors/Creators: |
|
Commentary on: |
Tesfaye, S., Sloan, G., Petrie, J. et al. (29 more authors)
(2022)
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
The Lancet, 400 (10353).
pp. 680-690.
ISSN 0140-6736
|
Copyright, Publisher and Additional Information: |
© 2023 Published by Elsevier Ltd. This is an author produced version of a paper subsequently published in The Lancet. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
Keywords: |
Humans; Pain; Drug Combinations |
Dates: |
- Published: 21 January 2023
- Published (online): 19 January 2023
- Accepted: 19 December 2022
|
Institution: |
The University of Sheffield |
Academic Units: |
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research |
Funding Information: |
NATIONAL INSTITUTE FOR HEALTH RESEARCH nan NATIONAL INSTITUTE FOR HEALTH RESEARCH 15/35/03 DEPARTMENT OF HEALTH AND SOCIAL CARE UNSPECIFIED |
Depositing User: |
Symplectic Sheffield |
Date Deposited: |
03 Feb 2023 18:06 |
Last Modified: |
19 Jul 2023 00:13 |
Status: |
Published |
Publisher: |
Elsevier BV |
Refereed: |
Yes |
Identification Number: |
10.1016/s0140-6736(23)00057-0 |
Related URLs: |
|
Open Archives Initiative ID (OAI ID): |
oai:eprints.whiterose.ac.uk:196050 |